However, as previous studies have shown that p53 mutations are rare in melanoma and because both p53 “loss” and MDM2 expression are mechanisms that work by blocking p53 function in the tumor suppressor pathway, we decided to focus our attention on MDM2. This evidence concerns the gene TP53 and neoplasm.